Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism

Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism

<p>Abstract</p> <p>Background</p> <p>Olanzapine long-acting injection (LAI) is a salt-based depot antipsychotic combining olanzapine and pamoic acid. The slow intramuscular dissolution of this practically insoluble salt produces an extended release of olanzapine lasting...

Full description

Bibliographic Details
Main Authors: Stickelmeyer Mary, Johnson Jason, Kothare Prajakti, Bergstrom Richard F, Detke Holland C, McDonnell David P, Sanchez-Felix Manuel V, Sorsaburu Sebastian, Mitchell Malcolm I
Format: Article
Language:English
Published: BMC 2010-06-01
Series:BMC Psychiatry
Online Access:http://www.biomedcentral.com/1471-244X/10/45

Internet

http://www.biomedcentral.com/1471-244X/10/45

Similar Items